Frontier Biotechnologies Inc. (SHA:688221)
China · Delayed Price · Currency is CNY 17.73
-0.15 (-0.84%)
Last updated: Aug 27, 2025
Frontier Biotechnologies Market Cap
Frontier Biotechnologies has a market cap or net worth of 6.47 billion as of August 28, 2025. Its market cap has increased by 224.81% in one year.
Market Cap
6.47B
Enterprise Value
6.11B
Revenue
133.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.73
Market Cap Chart
Since October 28, 2020, Frontier Biotechnologies's market cap has decreased from 10.76B to 6.47B, a decrease of -39.85%. That is a compound annual growth rate of -9.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 6.47B | 77.05% |
| Dec 31, 2024 | 3.66B | -1.61% |
| Dec 29, 2023 | 3.72B | -42.53% |
| Dec 30, 2022 | 6.47B | -3.33% |
| Dec 31, 2021 | 6.69B | -3.43% |
| Dec 31, 2020 | 6.93B | -35.64% |
| Oct 28, 2020 | 10.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 440.86B |
| Shenzhen Mindray Bio-Medical Electronics | 296.91B |
| WuXi AppTec | 292.07B |
| Sichuan Biokin Pharmaceutical | 132.33B |
| Zhangzhou Pientzehuang Pharmaceutical., | 129.10B |
| Aier Eye Hospital Group | 127.82B |
| Shanghai United Imaging Healthcare | 111.40B |
| Yunnan Baiyao Group Co.,Ltd | 103.47B |